Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


11th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Christo John Frederick Muller

Christo John Frederick Muller

Biomedical Research and Innovation Platform, South Africa

Title: Effects of Rooibos on microbiota dysbiosis: implications for diet-induced metabolic dysfunction


Biography: Christo John Frederick Muller


Recent research indicates that the gut microbiota plays a crucial role in maintaining health or promoting metabolic diseases such as obesity and diabetes. Modulation of the gut microbiome composition by enhancing the polyphenol content of the diet has potentiality in health improvement and even disease prevention. Rooibos (Aspalathus linearis) is known to exhibit such preventive effects against metabolic diseases such as diabetes. We propose that a major factor mediating these effects is through the regulation of gut microbiota by Rooibos polyphenols. We used a high fat and sugar diet-induced non-human diabetic primate model (n=6) to elucidate the effects of Rooibos on GUT microbiota. In the study, we evaluated the effect of 4 weeks of supplementation (90 mg/kg body weight) with a pharmaceutical grade aspalathin-enriched green rooibos extract (Afriplex GRT) containing ca. 12.8% aspalathin, on the gut microbiota of high fat diet-induced diabetic and normal vervet monkeys (Chlorocebus aethiops).  Stools collected before and during treatment were analyzed by Microbial DNA qPCR array. The 28-day treatment of the monkeys with GRT extract, improved glucose tolerance, lowered cholesterol, specifically LDL-cholesterol in the blood. In addition, Afriplex GRT significantly affected bacteria deemed to be characteristic of the microbiota phenotype harmful to the metabolism as seen in the shifts between normal monkeys on a maize diet compared to diabetic monkeys on a high fat and sugar diet. The Firmicutes to Bacteroidetes (F/B) ratio, increased in the diabetic monkeys, was reduced by the treatment, that correlated with improved blood glucose and lipid parameters. Key bacterial species increased by the GRT treatment, include: Akkermansia muciniphila, Bacteroides intestinalis, Desulfovibrio piger and Bifidobacterium adolescentis. Supplementation of the diabetic animals Afriplex GRT treatment improved several microbial species relevant to human metabolic diseases in high fat and sugar fed diabetic vervet monkeys. 

Speaker Presentations

Speaker PDFs